Skip to main content

Month: March 2022

Eisai Opens New U.S. HQ at ON3 Campus; Will Bring 800 Jobs to Nutley

Eisai Inc., the U.S. pharmaceutical subsidiary of Japan’s Eisai Co. Ltd., officially relocated its U.S. headquarters from Woodcliff Lake to the ON3 complex in Nutley. The move brings approximately 800 jobs to the area and, at full capacity, the new state-of-the-art facility will accommodate 1,300 employees.

Eisai Inc. Opens New US Headquarters on ON3 Campus in Nutley

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., has relocated its US headquarters to the ON3 Campus at 200 Metro Blvd. in Nutley. The move supports Eisai’s new hybrid workstyle and human health care mission to deliver life-changing therapies and health-related solutions.